Clinical Trials in Northern California

Center For Dermatology Clinical Research Inc. sets a standard of excellence by offering core expertise in conducting Phase 1-4 dermatology clinical trials and post-marketing trials. Founded in 2003, we strive to provide excellent patient care to meet the needs of the community in clinical research. Our staff is comprised of experienced, trained professionals who perform clinical trials to complete the rigorous approval process required by the FDA.

For over 20 years,

The Center has managed clinical trials for a wide range of dermatologic issues including eczema, psoriasis, acne, onychomycosis (toenail fungus), tineapedis (foot fungus), botox/fillers, cosmetic topical products, lasers, and many others.

We adhere to strict ethical and procedural standards when testing pharmaceutical and cosmetic products. This offers residents throughout Northern California the opportunity to participate in the approval process for new medications, therapy, and devices to treat their dermatologic conditions.

Why should you participate in a clinical trial?

In a clinical trial, human volunteers are given an intervention such as a medical product or procedure or a change in their lifestyle or behaviors. In some cases, they may be given a placebo – a product or procedure with no effect – in order to compare outcomes between people who receive a medical intervention and those who do not. Researchers measure specific outcomes in each volunteer to determine the safety and effectiveness of the intervention or lifestyle/behavior change in addressing the condition it is designed to manage or alleviate. Clinical trials contribute to the advancement of medical science and have led to an increased quality of life for people with medical conditions such as cancer, diabetes, HIV, and more. Clinical research is regulated by the Food and Drug Administration, and the Center for Dermatology Clinical Research Inc. adheres to strict ethical and procedural standards to ensure the safety of all volunteers.

A Standard Of Excellence: Offering Phase 1-4 Clinical Trials for Dermatologic Conditions

such as adult acne, alopecia areata, eczema, atopic dermatitis, psoriasis, acne, onychomycosis (toenail fungus), tineapedis (foot fungus), botox/fillers, cosmetic topical products, lasers, and many others.

Why choose Center for Dermatology Clinical Research Inc.?

Over 20 years of experience initiating, managing, and successfully completing clinical trials

Highly skilled physicians, medical assistants, and clinical research coordinators

Proven track record of results

Empathetic approach to patient care

Ready to learn more about volunteering for a clinical trial?

Learn more about our current trials or sign up to be notified first about new and upcoming clinical trials at Center for Dermatology Clinical Research Inc.

View Current Studies

we’re here to answer all your questions

If you have questions please contact us and we will be in touch.

What is a clinical study?

A clinical study involves research using human volunteers (also called participants) that is intended to add to medical knowledge. There are two main types of clinical studies: clinical trials and observational studies. ClinicalTrials.gov includes both interventional and observational studies.

Who can participate in a clinical study?

The factors that allow someone to participate in a clinical study are called inclusion criteria, and the factors that disqualify someone from participating are called exclusion criteria. These are based on things such as age, gender, the type and stage of a disease, previous treatment history, and other medical conditions.

How much does it cost to participate in clinical trials?

Free! There is no cost to participants who participate in clinical trials to receive treatment in relation to ongoing trials.

How are participants protected?

In addition to being monitored by an IRB, some clinical studies are also monitored by data monitoring committees (also called data safety and monitoring boards). Various Federal agencies, including the Office of Human Subjects Research Protection (OHRP) and FDA, have the authority to determine whether sponsors of certain clinical studies are adequately protecting research participants.